A detailed history of Atria Investments LLC transactions in Vericel Corp stock. As of the latest transaction made, Atria Investments LLC holds 7,952 shares of VCEL stock, worth $413,504. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,952
Previous 7,768 2.37%
Holding current value
$413,504
Previous $328,000 32.93%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$40.05 - $59.11 $7,369 - $10,876
184 Added 2.37%
7,952 $436,000
Q3 2024

Nov 01, 2024

BUY
$42.25 - $53.56 $58,220 - $73,805
1,378 Added 21.56%
7,768 $328,000
Q2 2024

Aug 13, 2024

BUY
$41.71 - $52.9 $266,526 - $338,031
6,390 New
6,390 $293,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.45B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.